Basic Colofac Information

• INN (International Nonproprietary Name): Mebeverine.
• Brand Names Available In United Kingdom: Colofac®; Aurobeverine®.
• Forms & Dosages Sold: Standard tablets 135 mg (1 tablet three times daily); Prolonged‑release capsules 200 mg (1 capsule twice daily); Oral liquid for swallowing difficulties.
• ATC Code: A03AA04 — Drugs for functional gastrointestinal disorders, synthetic anticholinergics, esters with tertiary amino group.
• Manufacturers In United Kingdom: Major originator listed as Abbott Laboratories / Mylan (now part of Viatris), with generics supplied by manufacturers such as Teva, Mylan and Zentiva.
• Registration Status In United Kingdom: Colofac and generics are officially authorised for OTC and prescription dispensing by the MHRA.
• OTC / Rx Classification: OTC in some UK pharmacy outlets for small packs; prescription available for larger or modified‑release formulations depending on supplier.
• Storage And Handling: Store in original blister packaging below 25°C, protect from moisture and light; keep out of reach of children.
• Patient Groups And Dosing Notes: Not recommended for children under 10 years; standard adult dosing generally appropriate for elderly; use with caution in severe hepatic or renal impairment.

Latest Research Highlights (UK + EU, 2022–2025)

Worried whether Colofac actually works beyond placebo?

Recent UK and EU literature from 2022–2025 describes heterogeneous evidence for mebeverine in irritable bowel syndrome (IBS).

Meta‑analyses report a small‑to‑moderate symptomatic benefit over placebo for cramp‑related pain, with variable effects on bowel habit and bloating.

Pragmatic NHS primary‑care audits and secondary‑care service evaluations note meaningful patient‑reported relief in a subset of patients when mebeverine is combined with dietary advice and low‑FODMAP guidance.

Safety signals remain rare, and pharmacovigilance data continue to show a low incidence of serious adverse events.

Research priorities highlighted in this period include better phenotyping (IBS‑D, IBS‑C, mixed), longer‑term safety registries and head‑to‑head trials versus peppermint oil and hyoscine.

Key adverse event rates reported in audits and Yellow Card style summaries are low, with common side effects listed as rare in product registries and clinical summaries.

Clinical Effectiveness In The UK (NHS Outcomes & Patient Reports)

Are patients in the UK actually seeing benefit from Colofac?

Clinical practice across NHS primary care and community pharmacy shows mebeverine is commonly used for abdominal cramping and spasm‑predominant IBS.

NHS audit data and patient‑reported outcome measures indicate measurable pain reduction for many patients, particularly where spasm is the dominant symptom.

Adherence in real life often depends on onset of benefit, typically days to a few weeks, and on tolerability.

Pharmacists at major chains and independent outlets report frequent OTC enquiries, and GPs often include mebeverine in a stepped plan alongside lifestyle changes, fibre modification and psychological therapies when appropriate.

Limitations include high placebo responses in IBS trials and variable trial quality, so decisions are based on individual response and shared decision‑making.

• Outcome Measures Used In Audits:
• Patient‑reported pain scores.
• Global symptom improvement scales.
• Quality of life and days off work.
• Need for additional medication or referral.

Indications & Expanded Uses (MHRA‑Approved And Off‑Label)

What is Colofac officially used for, and when do clinicians use it off‑label?

MHRA‑authorised indication: symptomatic relief of abdominal pain and cramps associated with irritable bowel syndrome and non‑specific gut spasm.

Off‑label uses in UK practice can include colicky pain due to benign functional gut spasm and adjunctive treatment of post‑infectious IBS when spasm predominates.

Colofac is not appropriate for acute severe abdominal pain of unknown cause; structural or surgical causes must be excluded first.

• Approved: Symptomatic relief of abdominal pain and cramps in IBS and non‑specific gut spasm.
• Off‑Label: Colicky functional gut spasm; adjunct in post‑infectious IBS with spasm predominance.
• Contraindicated Situations: Acute severe undiagnosed abdominal pain; paralytic ileus; hereditary sugar‑absorption disorders for some formulations.

Clinicians typically trial mebeverine for 2–8 weeks to establish benefit and stop if there is no improvement, with concurrent use of dietetic care such as low‑FODMAP guidance and gut‑directed psychological interventions as part of multidisciplinary pathways.

Composition & Brand Landscape (Active Ingredient, UK Brands, Packaging)

Which brands and strengths should pharmacists and patients expect to see on shelf?

Active substance: mebeverine (INN Mebeverine).

Originator and manufacturers include Abbott / Viatris and multiple generics from Teva, Mylan and Zentiva.

Pharmacists should flag generic interchangeability and clearly label differences between 135 mg tablets and 200 mg MR capsules to avoid dosing confusion.

Contraindications & Special Precautions (High‑Risk Groups)

Who must not take Colofac, and who needs closer monitoring?

• Absolute Contraindications:
• Hypersensitivity to mebeverine or any excipients.
• Known paralytic ileus.
• Hereditary galactose intolerance, Lapp lactase deficiency or glucose‑galactose malabsorption for certain formulations.

• Special Precautions / Relative Contraindications:
• Severe hepatic or renal impairment — limited data; use with caution.
• Acute porphyrias — unknown safety.
• Pregnancy — insufficient safety data; avoid unless clearly indicated.
• Breastfeeding — advised to avoid where possible; mebeverine present at low levels in milk.
• Elderly — standard dosing usually appropriate but monitor for adverse effects and polypharmacy.

Advise patients that dizziness or drowsiness is rare but possible and to assess ability before driving or operating machinery.

Counsel on alcohol moderation since alcohol can aggravate IBS symptoms.

Dosage Guidelines (Standard NHS‑Recommended Regimens And Adjustments)

How should patients take Colofac for typical IBS symptoms?

Standard adult dosing in UK practice is either 135 mg tablet three times daily or 200 mg prolonged‑release capsule twice daily, depending on formulation.

Not recommended for children under 10 years; elderly patients generally use the standard adult dose unless comorbidity suggests otherwise.

Oral liquid formulations are available for swallowing difficulties with an equivalent dose.

Review treatment after two weeks and reassess if symptoms persist beyond a month.

Missed dose guidance: take when remembered unless near next dose; do not double up.

Overdose is rarely serious; manage symptomatically and seek medical review if severe.

Interactions Overview (Drugs, Food, MHRA Yellow Card Signals)

Will Colofac interact with my other medicines or lifestyle choices?

Mebeverine has few clinically significant drug interactions and is not strongly anticholinergic.

There are rare reports of false‑positive amphetamine results on some urine drug screens and very rare ocular events such as drug‑induced angle‑closure glaucoma.

Monitor agents that affect gastrointestinal motility if used concomitantly, and counsel that alcohol and caffeine can aggravate IBS symptoms even though formal pharmacokinetic interactions are not demonstrated.

• Pharmacy SOP Interaction Checks:
• Review concomitant antimuscarinic agents and CNS depressants.
• Ask about urine drug screening needs and inform patients of rare false‑positive reports.
• Advise moderation of alcohol and caffeine to limit symptom aggravation.

Reporting A Yellow Card: Suspected adverse reactions in the UK should be reported to the MHRA Yellow Card scheme so national safety signals are captured.

Cultural Perceptions & Patient Habits (UK Patient Behaviour & Trust)

What do UK patients usually expect when seeking help for IBS?

Many people in the UK seek pharmacist advice first for IBS symptoms and place high trust in NHS advice lines and face‑to‑face pharmacy counselling.

Online forums contain mixed personal accounts: some patients report good symptom control with Colofac, others prefer dietary approaches or alternative remedies.

There is a cultural preference for stepwise conservative management — diet, fibre, OTC remedies — prior to escalation to prescription medicine.

Electronic prescriptions and online pharmacy services have increased access, but pharmacists remain key gatekeepers and educators in community care.

• Common Patient Beliefs And Suggested Pharmacist Responses:
• "I need something quick for cramps" — Explain onset may be days to weeks and offer symptom relief options and safety counselling.
• "Will diet help more than tablets?" — Validate diet first; recommend low‑FODMAP referral and explain mebeverine is often used alongside dietetic care.
• "Is this safe long term?" — Reassure that mebeverine is non‑habit forming and long‑term use is acceptable under supervision.

Availability & Pricing Patterns (Boots, LloydsPharmacy, Superdrug, NHS)

Where can I buy Colofac and how much should I expect to pay?

Colofac and generics are widely stocked across Boots, LloydsPharmacy, Superdrug and independent pharmacies, with some packs available OTC and others supplied on prescription.

On NHS prescription in England patients normally pay a per‑item charge unless exempt, whereas prescriptions are free in Scotland, Wales and Northern Ireland; this influences private purchase patterns.

Online pharmacies and e‑prescription services have made access simpler, and our online pharmacy offers Colofac without a prescription with discreet delivery to United Kingdom in 5‑14 days.

For cost‑sensitive patients, pharmacists should highlight generic options, NHS prescription routes and appropriate pack size to reduce waste.

Comparable Medicines And Preferences (NHS Prescribing Alternatives)

What other antispasmodics might my GP or pharmacist suggest instead of Colofac?

Colofac is often preferred when anticholinergic side‑effects are a concern, as mebeverine lacks strong systemic antimuscarinic action.

FAQ Section

1. How quickly will Colofac work? Some patients notice reduced cramp within days but it is reasonable to assess response over 2–8 weeks.
2. Can I take it while breastfeeding or pregnant? Data are limited; avoid unless advised by a clinician and discuss risks and benefits with your GP.
3. Is it addictive or habit‑forming? No — mebeverine is non‑habit forming and may be used long term under medical supervision.
4. Can I drive while taking Colofac? Rare dizziness has been reported; do not drive if you feel affected.

When To Seek Urgent Care:

If you develop severe or worsening abdominal pain, fever, vomiting, blood in stool or signs of obstruction, contact NHS 111 or your GP immediately and seek emergency care if severe.

Guidelines For Proper Use (Pharmacist Counselling & NHS Patient Portals)

What should a pharmacist cover when recommending Colofac?

• Confirm symptoms are consistent with functional IBS and not acute surgical abdomen.
• Review absolute contraindications, including paralytic ileus and hereditary sugar‑absorption disorders.
• Explain dosing differences: 135 mg TDS versus 200 mg MR BD, and advise on avoiding crushing MR capsules.
• Set realistic expectations: trial period 2–8 weeks; benefit may be modest and individual.
• Advise on possible side effects such as rare dizziness, headache, gastrointestinal upset and allergic reactions.
• Give missed dose advice and storage instructions.
• Signpost to NHS self‑help pages, local dietetic services and psychological therapies where available.
• Arrange or recommend GP review if no improvement after two weeks or if red‑flag symptoms appear.

Patient Leaflet Template (Short):

What Colofac Is For: Symptomatic relief of abdominal pain and cramps in IBS.

How To Take: 135 mg tablet three times daily, or 200 mg MR capsule twice daily as directed.

Side Effects: Rare dizziness, headache, skin reactions, gastrointestinal upset; stop and seek advice if severe allergic reaction occurs.

Storage: Store below 25°C in original pack and keep away from children.

Further Help: Contact your pharmacist, GP or NHS 111 for urgent concerns and local referrals to dietetic or psychological support services.

Delivery Across United Kingdom